Sunmark Nicotine Transdermal System Step 2 Stop Smoking Aid, 14 mg, 14 patches
Product Description
Size: 14 ea Habitrol Nicotine Transdermal System Patch Stop Craving, Start Saving. The Habitrol Nicotine Transdermal System Patch is a nicotine transdermal system skin patch containing nicotine, the addictive agent in cigarettes and other tobacco products. Habitrol Nicotine Transdermal System Patch use time released technology for sustained delivery of nicotine for effective, long lasting, craving reduction. When you wear the patch, it gradually releases nicotine into your bloodstream through the skin. The Habitrol Nicotine Transdermal System Patch works by replacing some of the nicotine which your body has become accustomed to from smoking, reducing the nicotine withdrawal symptoms many people normally feel when they stop smoking. Your own chances of quitting depend on how strongly you are addicted to nicotine, how motivated you are to quit smoking, and how closely you follow a quit program plan. Understanding How Nicotine Addition Affects Your Mind and Body As you know, smoking cigarettes is addictive. Your brain and body get used to functioning with a certain level of nicotine when you are smoking. Within a few hours of your last cigarette, your nicotine level drops dramatically, resulting in withdrawal symptoms for most smokers. Common nicotine withdrawal symptoms include intense cravings for nicotine, irritability, anxiety, depression, restlessness, difficulty concentrating, difficulty sleeping and increased appetite. Physical withdrawal symptoms usually peak within 24 to 72 hours after your last cigarette, then decline over the next several weeks. Some smokers, however, may experience nicotine withdrawal symptoms for several months. Staying on Habitrol Nicotine Transdermal System Patch for the full 8 weeks can reduce the withdrawal symptoms and cravings you experience and help you quit smoking. It's Never Too Late to Stop Smoking Most of us recognize the risks of smoking, such as cancer, heart disease and emphysema. We also know that second-
